BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28446316)

  • 21. Prognostic significance of NOTCH1 and FBXW7 mutations in pediatric T-ALL.
    Erbilgin Y; Sayitoglu M; Hatirnaz O; Dogru O; Akcay A; Tuysuz G; Celkan T; Aydogan G; Salcioglu Z; Timur C; Yuksel-Soycan L; Ure U; Anak S; Agaoglu L; Devecioglu O; Yildiz I; Ozbek U
    Dis Markers; 2010; 28(6):353-60. PubMed ID: 20683149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The characteristics and prognostic impact of NOTCH1/FBXW7 mutation and CDKN2A/B deletion in adult T-cell acute lymphoblastic leukemia patients].
    Fang QY; Hao QS; Gong XY; Wang J; Li QH; Yuan T; Tian Z; Liu KQ; Li Y; Liu YT; Gong BF; Wang Y; Wei H; Zhou CL; Lin D; Liu BC; Wei SN; Zhang GJ; Wang JX; Mi YC
    Zhonghua Xue Ye Xue Za Zhi; 2021 May; 42(5):432-435. PubMed ID: 34218589
    [No Abstract]   [Full Text] [Related]  

  • 23. FBXW7 and NOTCH1 mutations in childhood T cell acute lymphoblastic leukaemia and T cell non-Hodgkin lymphoma.
    Park MJ; Taki T; Oda M; Watanabe T; Yumura-Yagi K; Kobayashi R; Suzuki N; Hara J; Horibe K; Hayashi Y
    Br J Haematol; 2009 Apr; 145(2):198-206. PubMed ID: 19245433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic mutational profiling analysis of T cell acute lymphoblastic leukemia reveal mutant FBXW7 as a prognostic indicator for inferior survival.
    Yuan L; Lu L; Yang Y; Sun H; Chen X; Huang Y; Wang X; Zou L; Bao L
    Ann Hematol; 2015 Nov; 94(11):1817-28. PubMed ID: 26341754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent Advances in the Biology and Treatment of T Cell Acute Lymphoblastic Leukemia.
    Hefazi M; Litzow MR
    Curr Hematol Malig Rep; 2018 Aug; 13(4):265-274. PubMed ID: 29948644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of novel NOTCH1 mutations: increasing our knowledge of the NOTCH signaling pathway.
    Gallo Llorente L; Luther H; Schneppenheim R; Zimmermann M; Felice M; Horstmann MA
    Pediatr Blood Cancer; 2014 May; 61(5):788-96. PubMed ID: 24249312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomic characterization of pediatric T-cell acute lymphoblastic leukemia reveals novel recurrent driver mutations.
    Spinella JF; Cassart P; Richer C; Saillour V; Ouimet M; Langlois S; St-Onge P; Sontag T; Healy J; Minden MD; Sinnett D
    Oncotarget; 2016 Oct; 7(40):65485-65503. PubMed ID: 27602765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutations of NOTCH1, FBXW7, and prognosis in T-lineage acute lymphoblastic leukemia.
    Mullighan CG
    Haematologica; 2009 Oct; 94(10):1338-40. PubMed ID: 19794079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence and prognostic relevance of genetic variations in T-cell lymphoblastic lymphoma in childhood and adolescence.
    Bonn BR; Rohde M; Zimmermann M; Krieger D; Oschlies I; Niggli F; Wrobel G; Attarbaschi A; Escherich G; Klapper W; Reiter A; Burkhardt B
    Blood; 2013 Apr; 121(16):3153-60. PubMed ID: 23396305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The molecular profile of adult T-cell acute lymphoblastic leukemia: mutations in RUNX1 and DNMT3A are associated with poor prognosis in T-ALL.
    Grossmann V; Haferlach C; Weissmann S; Roller A; Schindela S; Poetzinger F; Stadler K; Bellos F; Kern W; Haferlach T; Schnittger S; Kohlmann A
    Genes Chromosomes Cancer; 2013 Apr; 52(4):410-22. PubMed ID: 23341344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NOTCH1 pathway activating mutations and clonal evolution in pediatric T-cell acute lymphoblastic leukemia.
    Kimura S; Seki M; Yoshida K; Shiraishi Y; Akiyama M; Koh K; Imamura T; Manabe A; Hayashi Y; Kobayashi M; Oka A; Miyano S; Ogawa S; Takita J
    Cancer Sci; 2019 Feb; 110(2):784-794. PubMed ID: 30387229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NOTCH mutations as prognostic markers in T-ALL.
    Ferrando A
    Leukemia; 2010 Dec; 24(12):2003-4. PubMed ID: 21157484
    [No Abstract]   [Full Text] [Related]  

  • 33. Diverse mutations and structural variations contribute to Notch signaling deregulation in paediatric T-cell lymphoblastic lymphoma.
    Salmerón-Villalobos J; Ramis-Zaldivar JE; Balagué O; Verdú-Amorós J; Celis V; Sábado C; Garrido M; Mato S; Uriz J; Ortega MJ; Gutierrez-Camino A; Sinnett D; Illarregi U; Carron M; Regueiro A; Galera A; Gonzalez-Farré B; Campo E; Garcia N; Colomer D; Astigarraga I; Andrés M; Llavador M; Martin-Guerrero I; Salaverria I
    Pediatr Blood Cancer; 2022 Nov; 69(11):e29926. PubMed ID: 36000950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NOTCH1 and FBXW7 mutations have a favorable impact on early response to treatment, but not on outcome, in children with T-cell acute lymphoblastic leukemia (T-ALL) treated on EORTC trials 58881 and 58951.
    Clappier E; Collette S; Grardel N; Girard S; Suarez L; Brunie G; Kaltenbach S; Yakouben K; Mazingue F; Robert A; Boutard P; Plantaz D; Rohrlich P; van Vlierberghe P; Preudhomme C; Otten J; Speleman F; Dastugue N; Suciu S; Benoit Y; Bertrand Y; Cavé H;
    Leukemia; 2010 Dec; 24(12):2023-31. PubMed ID: 20861920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pediatric-inspired intensified therapy of adult T-ALL reveals the favorable outcome of NOTCH1/FBXW7 mutations, but not of low ERG/BAALC expression: a GRAALL study.
    Ben Abdelali R; Asnafi V; Leguay T; Boissel N; Buzyn A; Chevallier P; Thomas X; Lepretre S; Huguet F; Vey N; Escoffre-Barbe M; Tavernier E; Reman O; Fegueux N; Turlure P; Rousselot P; Cahn JY; Lheritier V; Chalandon Y; Béné MC; Macintyre E; Dombret H; Ifrah N;
    Blood; 2011 Nov; 118(19):5099-107. PubMed ID: 21835957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequential mutations in Notch1, Fbxw7, and Tp53 in radiation-induced mouse thymic lymphomas.
    Jen KY; Song IY; Banta KL; Wu D; Mao JH; Balmain A
    Blood; 2012 Jan; 119(3):805-9. PubMed ID: 22117044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Mutations of FBXW7 in Adult T-Cell Acute Lymphocytic Leukemia].
    Guo X; Zhang R; Ge Z; Xu JY; Li M; Qiao C; Qiu HR; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Jun; 23(3):612-8. PubMed ID: 26117003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pediatric-Like Acute Lymphoblastic Leukemia Therapy in Adults With Lymphoblastic Lymphoma: The GRAALL-LYSA LL03 Study.
    Lepretre S; Touzart A; Vermeulin T; Picquenot JM; Tanguy-Schmidt A; Salles G; Lamy T; Béné MC; Raffoux E; Huguet F; Chevallier P; Bologna S; Bouabdallah R; Benichou J; Brière J; Moreau A; Tallon-Simon V; Seris S; Graux C; Asnafi V; Ifrah N; Macintyre E; Dombret H
    J Clin Oncol; 2016 Feb; 34(6):572-80. PubMed ID: 26644537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of complex NOTCH1 mutations on survival in paediatric T-cell leukaemia.
    Mansur MB; Hassan R; Barbosa TC; Splendore A; Jotta PY; Yunes JA; Wiemels JL; Pombo-de-Oliveira MS
    BMC Cancer; 2012 Jan; 12():9. PubMed ID: 22225590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NOTCH1 activation clinically antagonizes the unfavorable effect of PTEN inactivation in BFM-treated children with precursor T-cell acute lymphoblastic leukemia.
    Bandapalli OR; Zimmermann M; Kox C; Stanulla M; Schrappe M; Ludwig WD; Koehler R; Muckenthaler MU; Kulozik AE
    Haematologica; 2013 Jun; 98(6):928-36. PubMed ID: 23349303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.